Synthetic bicyclic iminosugar derivatives fused thiazolidin-4-one as new potential HIV-RT inhibitors

被引:18
|
作者
Chen, Hua [1 ]
Yang, Tianyu [1 ]
Wei, Sinan [1 ]
Zhang, Hongzhi [1 ]
Li, Rui [1 ]
Qin, Zhanbin [1 ]
Li, Xiaoliu [1 ]
机构
[1] Hebei Univ, Coll Chem & Environm Sci, Key Lab Chem Biol Hebei Prov, Baoding 071002, Peoples R China
基金
中国国家自然科学基金;
关键词
Bicyclic azasugar; Thiazolidin-4-one; HIV-RT inhibitor; Pummerer rearrangement; PUMMERER REACTION; INDOLIZIDINES;
D O I
10.1016/j.bmcl.2012.09.100
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel bicyclic iminosugar derivatives fused thiazolidin-4-one were conveniently synthesized by double Pummerer rearrangements, and their HIV reverse transcriptase (RT) inhibitory activities were preliminary examined. The notable anti-HIV-RT activity demonstrated that such bicyclic azasugars hold potential as a new kind of HIV-RT inhibitors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7041 / 7044
页数:4
相关论文
共 50 条
  • [31] A series of thiazole derivatives bearing thiazolidin-4-one as non-competitive ADAMTS-5 (aggrecanase-2) inhibitors
    Atobe, Masakazu
    Maekawara, Naomi
    Ishiguro, Noriko
    Sogame, Shinya
    Suenaga, Yoshihito
    Kawanishi, Masashi
    Suzuki, Hiroko
    Jinno, Norimasa
    Tanaka, Eiichi
    Miyoshi, Shiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2106 - 2110
  • [32] Sonochemical synthesis of New Thiazolidin-4-one derivatives as potent anticancer and antimicrobial agents with Docking design, and Energy gap estimation
    Hassan, Sangar Ali
    Ziwar, Jala Bahjat
    Aziz, Dara muhammed
    Abdullah, Media Noori
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1301
  • [33] Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents
    Abbas, Hebat-Allah S.
    Abd El Karim, Somaia S.
    BIOORGANIC CHEMISTRY, 2019, 89
  • [34] Synthesis of new heterocycles via methylenebis(2-(2-methoxyphenyl)thiazolidin-4-one) as potential anticancer agents
    Srinivas, Avula
    Rajitha, Sonti Reddy
    ORGANIC COMMUNICATIONS, 2022, 15 (02) : 96 - 107
  • [35] Synthesis of new 1,4-benzodioxin derivatives containing thiazolidin-4-one skeleton, molecular modelling and docking as antibacterial agents
    Guo, Xiao-Meng
    Liu, Cai-Shi
    Tong, Jin-Peng
    Wang, Ze-Lin
    Feng, Xing-Kai
    Li, Dong-Dong
    Wu, Yuan-Feng
    Sun, Juan
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1322
  • [36] SYNTHESIS, IDENTIFICATION OF SOME NEW TETRAZOLINE, THIAZOLIDIN-4-ONE AND IMIDAZOLIDIN-4-ONE DERIVATIVES AND EVALUATION ANTICANCER OF THEIR MOLECULAR DOCKING AND ANTI-OXIDANT EXPERIMENTAL
    AL-tamimi, Mohammed B. Wathiq
    Al-Majidi, Suaad M. H.
    3C TIC, 2023, 12 (01): : 83 - 116
  • [37] Synthesis and Antimicrobial Activity of Some New Thiazolidin-4-one Derivatives of 4-(6-methylbenzo[d]thiazol-2-yl)benzamine
    Hussein, Awaz Jamil
    Azeez, Hashim Jalal
    JOURNAL OF CHEMISTRY, 2013, 2013
  • [38] Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors
    Salve, Preeti S.
    Parchure, Prajakta
    Araujo, Lisel
    Kavalapure, Rohini S.
    Jalalpure, Sunil S.
    Sriram, Dharmarajan
    Krishna, Vagolu Siva
    Estharla, Madhu Rekha
    Alegaon, Shankar G.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [39] Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors
    Preeti S. Salve
    Prajakta Parchure
    Lisel Araujo
    Rohini S. Kavalapure
    Sunil S. Jalalpure
    Dharmarajan Sriram
    Vagolu Siva Krishna
    Madhu Rekha Estharla
    Shankar G. Alegaon
    Future Journal of Pharmaceutical Sciences, 7
  • [40] New thiourea and 1,3-thiazolidin-4-one derivatives effective on the HIV-1 virus
    Bielenica, Anna
    Sanna, Giuseppina
    Madeddu, Silvia
    Struga, Marta
    Jozwiak, Michal
    Koziol, Anna E.
    Sawczenko, Aleksandra
    Materek, Ilona B.
    Serra, Alessandra
    Giliberti, Gabriele
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (05) : 883 - 891